These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18287215)

  • 1. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
    Harris AK; Elgebaly MM; Li W; Sachidanandam K; Ergul A
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1213-9. PubMed ID: 18287215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.
    Sachidanandam K; Elgebaly MM; Harris AK; Hutchinson JR; Mezzetti EM; Portik-Dobos V; Ergul A
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2743-9. PubMed ID: 18424628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes.
    Li W; Sachidanandam K; Ergul A
    Neurol Res; 2011 Mar; 33(2):185-91. PubMed ID: 21801593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes.
    Abdelsaid M; Ma H; Coucha M; Ergul A
    Life Sci; 2014 Nov; 118(2):263-7. PubMed ID: 24434796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of endothelin receptor A antagonism on basilar artery endothelium-dependent relaxation after ischemic stroke.
    Coucha M; Li W; Ergul A
    Life Sci; 2012 Oct; 91(13-14):676-80. PubMed ID: 22365958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1.
    Sachidanandam K; Harris A; Hutchinson J; Ergul A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1016-21. PubMed ID: 16741041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
    Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
    Sudoh K; Yuyama H; Noguchi Y; Fujimori A; Ukai M; Ohtake A; Sato S; Sasamata M; Miyata K
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S390-3. PubMed ID: 15838329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
    Rafnsson A; Shemyakin A; Pernow J
    Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
    Yuyama H; Noguchi Y; Fujimori A; Ukai M; Fujiyasu N; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
    Eur J Pharmacol; 2004 Sep; 498(1-3):171-7. PubMed ID: 15363992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein.
    Tykocki NR; Gariepy CE; Watts SW
    J Pharmacol Exp Ther; 2009 Jun; 329(3):875-81. PubMed ID: 19297422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic ethanol intake modulates vascular levels of endothelin-1 receptor and enhances the pressor response to endothelin-1 in anaesthetized rats.
    Tirapelli CR; Legros E; Brochu I; Honoré JC; Lanchote VL; Uyemura SA; de Oliveira AM; D'Orléans-Juste P
    Br J Pharmacol; 2008 Jul; 154(5):971-81. PubMed ID: 18469849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia.
    Guo QH; Tian YL; Wang Z; Li AY; Ma ZH; Guo YJ; Weiss JW; Ji ES; Chu L
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):449-57. PubMed ID: 23662699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes.
    Sachidanandam K; Portik-Dobos V; Harris AK; Hutchinson JR; Muller E; Johnson MH; Ergul A
    Diabetes; 2007 Nov; 56(11):2753-8. PubMed ID: 17670915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors.
    Just A; Olson AJ; Arendshorst WJ
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F660-8. PubMed ID: 14678950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin.
    Inscho EW; Imig JD; Cook AK; Pollock DM
    Br J Pharmacol; 2005 Dec; 146(7):1019-26. PubMed ID: 16231007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo.
    Thai TL; Arendshorst WJ
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F360-8. PubMed ID: 18524860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1.
    Harris AK; Hutchinson JR; Sachidanandam K; Johnson MH; Dorrance AM; Stepp DW; Fagan SC; Ergul A
    Diabetes; 2005 Sep; 54(9):2638-44. PubMed ID: 16123352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.